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rLeft bundle branch block (LBBB) is a frequent,
etiologically heterogeneous, clinically and diagnosti-
cally challenging entity. Approximately 2% of patients
referred for cardiac stress testing show stable or inter-
mittent LBBB (1). Although LBBB is a recognized
predictor of unfavorable cardiac outcome (2–4), the
prognosis primarily is determined by underlying car-
diac pathology, including coronary artery disease, hy-
pertension, idiopathic dilated cardiomyopathy, and
aortic valve stenosis (5,6).
See page 251
The presence of LBBB makes the electrocardio-
gram (ECG) uninterpretable for ischemia and,
therefore, a stress imaging technique is necessary for
the identification of coronary artery disease (7).
Despite the difficulty posed by abnormal wall mo-
tion, stress echocardiography is the best option for
the diagnosis of coronary artery disease (8–10): it is
more specific than perfusion imaging (8,10) and its
sensitivity is good, albeit reduced, in the left ante-
rior descending territory only in the presence of a
dyskinesis in the baseline echocardiogram (9). The
prognostic value of pharmacologic stress echocardi-
ography is excellent, additive when compared with
clinical and resting echocardiographic variables, and
especially pronounced in patients without myocar-
dial infarction (11). The negative predictive value of
stress echocardiography in these patients is similar
to that obtained with this technique and with
nuclear techniques in patients without conduction
abnormalities (12).
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13) demonstrate—in a patient population of a little
ore than 600—that exercise echocardiography
rovides significant prognostic information for pre-
iction outcome in those with LBBB. Patients with
normal exercise echocardiogram have a very good
rognosis, whereas those with abnormal results are
t increased risk of death and major cardiac events.
ouzas-Mosquera et al. (13) demonstrate the addi-
ive prognostic value of wall motion abnormalities
t peak exercise stress echocardiography in a pro-
pective study analyzing hard end points. This
vidence is another piece in the larger framework of
he prognostic power of stress echocardiography.
The present results are consistent with previous
tudies evaluating the outcome of patients with
BBB. The recommendations of the American Soci-
ty of Echocardiography and the European Associa-
ion of Echocardiography consider physical and phar-
acological stressors comparable in their diagnostic
nd prognostic accuracy and the choice of one over the
ther is strictly due to relative contraindications and
bility of patients to exercise (7,14). Both physical and
harmacological stress echocardiography has been
reviously demonstrated to be accurate in identifying
he subset of patients at greater risk of experiencing
ard events in the follow-up in patients with LBBB
8–11,15). A recent meta-analysis confirmed the
rognostic accuracy of noninvasive imaging tech-
iques showing a relative risk 7-fold greater in the
resence of test positivity (16) in this subset of
atients.
Perhaps, however, we might expect more from
tress echocardiography in the evaluation of patients
ith LBBB. The yearly death rate in the group of
atients with a negative test is approximately 1%
13), almost double that compared with other
eports (12) and supporting the role of LBBB as the
anifestation of a subtle underlying cardiomyopa-
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261thy. If so, which are the stress echocardiographic
parameters that can be used in risk stratification
beyond wall motion analysis? Would it have also
been possible to risk stratify the negative subset
beyond the conventional wall motion analysis?
In the last few years several parameters, such as
coronary flow reserve and myocardial contractility,
have been added to stress echocardiography to identify
patients who, despite a negative test, have some risk of
becoming troublemakers in the long run. Coronary
flow reserve (CFR) evaluated by pulsed Doppler
echocardiography associated with vasodilator stress
recently has entered the stress echocardiography lab-
oratory (17). A reduced CFR is an additional param-
eter of severity of ischemia in the risk stratification of
the stress echocardiographic response, whereas pa-
tients with a negative test for wall motion criteria and
normal CFR have a favorable outcome during dipyr-
idamole stress echocardiography (18). The measure-
ment of CFR also provides independent prognostic
information in diabetic and nondiabetic patients with
known or suspected coronary artery disease and neg-
ative dipyridamole stress echocardiography for wall
motion criteria (19) and in patients with chest pain
syndrome and normal coronary arteries (20). The
prognostic impact of CFR also has been recently
proven in patients with nonischemic dilated cardio-
myopathy (21): an abnormal CFR detectable by
Doppler echocardiography identifies a subset of pa-
tients at greater risk of spontaneous events (death and
worsening of clinical status). The lack of increment of
end-systolic pressure-volume relationship evaluation
has been demonstrated to identify patients at greater
risk of mortality in the face of a negative test for wall
motion criteria (22).
Last, but not least, almost 30% of patients in the
present study were on antianginal medical therapy, 4%
on beta-blockers, 29% on nitrates, and 16% on cal-
cium channel blockers. Antianginal medical therapy
exerts a powerful effect on the diagnostic accuracy of
stress echocardiography (23,24), offsetting the recog-
nition of ischemic burden through a series of conven-2001;110:253–9. field LT, Saporitoischemic segments and severity of induced dysfunction
(both expressed by peak wall motion score index),
exercise workload, and time of onset of ischemia.
Drug therapy also has an important influence on the
evaluation of prognosis in patients with known or
suspected coronary artery disease. In the presence of
concomitant anti-ischemic therapy, a positive test is
more prognostically malignant and a negative test is
less prognostically benign (25). A spectrum of strati-
fication is possible among both positive and negative
test results. A large extent of inducible myocardial
ischemia expressed by the variation of wall motion
score index between rest and peak stress at a low
workload will identify patients with an underlying
severe coronary artery disease. It also is possible to
stratify the negative response into a spectrum of
different risks, including therapy at time of testing,
CFR on left anterior descending artery, and myocar-
dial contractility (Table 1). The addition of these
parameters to conventional stress echocardiography
will enrich the test, making it an extraordinary tool to
identify the risk of several classes of patients: those
with diabetes, pre-clinical cardiomyopathies, and mi-
crovascular disease as well as those with overt coronary
artery disease.
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Table 1. The Risk of Patients With a Negative Test Result
Risk Not So Low Very Low
Dose/load Submaximal Maximal
Diabetes  
Therapy  
Coronary ﬂow reserve 2 2
Force-frequency
relationship
Flat-biphasic Steep
Death/year 3% 1%
In patients at low risk, such as those with a negative test for wall motion
criteria, a small subset will be at risk in the long term according to other
parameters beyond wall motion analysis.tional stress echocardiographic parameters: number of 1, 56124 Pisa, Italy. E-mail: rosas@ifc.cnr.it.R E F E R E N C E S
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